Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · Real-Time Price · USD
0.351
-0.025 (-6.56%)
Nov 21, 2024, 10:52 AM EST - Market open
Cyclacel Pharmaceuticals Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 1 | 3 | 8 | 39 | 38 | 12 | |
| Market Cap Growth | -56.42% | -67.46% | -78.45% | 2.15% | 229.64% | 52.41% | |
| Enterprise Value | -2 | -3 | -15 | -1 | 16 | -0 | |
| Last Close Price | 0.37 | 2.67 | 10.00 | 58.35 | 117.15 | 201.00 | |
| PS Ratio | 9.06 | 6.48 | - | - | - | - | |
| PB Ratio | -2.01 | 4.48 | 0.52 | 1.03 | 1.14 | 0.99 | |
| P/TBV Ratio | - | 4.48 | 0.52 | 1.03 | 1.14 | 0.99 | |
| Debt / Equity Ratio | - | 0.06 | 0.01 | 0.00 | 0.03 | 0.10 | |
| Asset Turnover | 0.01 | 0.02 | - | - | - | - | |
| Quick Ratio | 0.47 | 0.77 | 3.06 | 7.44 | 13.97 | 5.46 | |
| Current Ratio | 0.77 | 0.91 | 3.25 | 7.56 | 14.27 | 5.79 | |
| Return on Equity (ROE) | -807.39% | -272.63% | -79.05% | -52.03% | -37.57% | -58.07% | |
| Return on Assets (ROA) | -108.63% | -86.33% | -48.56% | -35.01% | -25.51% | -34.45% | |
| Return on Capital (ROIC) | -574.73% | -190.64% | -64.29% | -38.85% | -28.16% | -42.98% | |
| Earnings Yield | -1839.10% | -828.75% | -253.45% | -47.57% | -22.23% | -67.95% | |
| FCF Yield | -592.23% | -249.10% | -47.85% | -21.14% | -82.06% | |
| Buyback Yield / Dilution | -115.38% | -13.38% | -26.10% | -145.67% | -345.23% | -34.95% | |
| Total Shareholder Return | -115.38% | -13.38% | -26.10% | -145.67% | -345.23% | -34.95% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.